CN Patent

CN108129482A — 一种巴瑞替尼的制备方法

Assigned to Jiangsu Zhongbang Pharmaceutical Coltd · Expires 2018-06-08 · 8y expired

What this patent protects

本发明公开了一种巴瑞替尼的制备方法,属于药物制备技术领域,该方法以4‑氯吡咯并嘧啶为起始原料,先进行氨基保护,后与水合肼及丙烯醛“一锅法”取代、关环得到中间4。起始原料1,3‑二溴丙酮和乙二醇缩合得到中间体5,中间体5与乙基磺酰胺缩合得到中间体6,中间体6与氰甲基磷酸二乙酯在强碱下反应制备得到中间体7,中间体4和中间体7在催化剂作用发生加成反应、脱保护得多目标产物1。该工艺反应条件温和,中间体纯化方法简单易行,总收率高达40~55%,适合工业化生产。

USPTO Abstract

本发明公开了一种巴瑞替尼的制备方法,属于药物制备技术领域,该方法以4‑氯吡咯并嘧啶为起始原料,先进行氨基保护,后与水合肼及丙烯醛“一锅法”取代、关环得到中间4。起始原料1,3‑二溴丙酮和乙二醇缩合得到中间体5,中间体5与乙基磺酰胺缩合得到中间体6,中间体6与氰甲基磷酸二乙酯在强碱下反应制备得到中间体7,中间体4和中间体7在催化剂作用发生加成反应、脱保护得多目标产物1。该工艺反应条件温和,中间体纯化方法简单易行,总收率高达40~55%,适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN108129482A
Jurisdiction
CN
Classification
Expires
2018-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Zhongbang Pharmaceutical Coltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.